2m 2m 2m 2m 2m 2m 2m
Ascendis Pharma Br (ASND)
NASDAQ
$253.29-$0.001 (-0.0004%)
Price as of Aug 21, 2026 7:32 PM EDT- $16.8BMarket Cap
- 30.36%1-Year Change
- BiotechnologyIndustry
Ascendis Pharma Br (ASND)
$253.29-$0.001 (-0.0004%)
ASND | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $253.29 | ||
Change | -$1.52 (-0.60%) | ||
Open | $253.62 | ||
High | $257.88 | ||
Low | $252.87 | ||
Previous Close | $254.81 | ||
Volume | 363,774 | ||
30-Day Average Volume | 522,233 | ||
1-Week Change | 1.93% | ||
1-Month Change | -0.75% | ||
1-Year Change | 30.36% | ||
3-Year Change | 170.90% | ||
5-Year Change | 110.29% | ||
Fundamentals | |||
Shares Outstanding | 66.2M | ||
Total Assets | $1.3B | ||
Market Cap | $16.8B | ||
Enterprise Value | $16.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue